Monthly Archives: December 2019

Kidoz Inc. Completes AGM and Provides Corporate Update

ANGUILLA, BWI / ACCESSWIRE / December 13, 2019 / Kidoz Inc. (TSXV:KIDZ) (the "Company"), kid-tech software developer, owner of the KIDOZ Safe Ad Network (www.kidoz.net), the KIDOZ Kid-Mode Operating System, and the Rooplay edu-games platform (www.rooplay.com), announced today that it completed its Annual General Meeting (AGM) in Anguilla B.W.I., added new sales houses covering 10 new countries, and posted the new Fundamental Research Corporation Research Report on Kidoz Inc.

At the AGM held November 27th, 2019, the Kidoz Inc. shareholders elected the Company's Board of Directors: Tarrnie Williams Sr. (Executive Chairman), Eldad Ben Tora and Jason Williams (Co-CEO's), Fiona Curtis, Claes Kalborg, Josef Mandelbaum, and Moshe David (Non-executive directors) as well as reappointed the Auditors, Davidson & Company and re-affirmed the Company's stock option plan. In addition, the Co-CEOs Eldad Ben Tora and Jason Williams provided an update to shareholders in attendance in Anguilla which highlighted the Company's strong Q3 2019 performance, an assortment of new global sales relationships, and the positive market factors for continued growth in 2020.

Kidoz has signed new agency sales house relationships in Brazil, Malaysia, India, and a multi-territory agreement covering seven countries in the Middle East. With the addition of these new sales agency relationships Kidoz now has local representation in more than 25 countries. Media sales agencies are excited to begin working with Kidoz because our inventory of mobile digital advertising is unique. The advertising options for global children's entertainment companies is limited due to strict rules by regulators, Google and Apple. Advertising with Kidoz provides compliance, brand safety, and high performance results.

"The forces we're seeing in the market are creating an excellent environment for the Kidoz Safe Advertising Platform and we continue to see growth in sales, traffic, and partners from many regions of the world," said Jason Williams Co-CEO. "As the Company grows and our technology is refined, we're able to streamline the on-boarding of new publisher partners of all sizes which adds value to our inventory through increased reach and performance. As our inventory increases in value we are able to close more deals and increase the average deal size which has a positive impact on our financial performance as can be seen in our Q3 2019 results. Management believes that the strong regulatory, consumer, and digital trends helping the Company to grow will continue in Q4 2019 and into fiscal 2020."

Finally, Kidoz has posted the most recent research report completed by Fundament Research Corporation regarding the Kidoz' Third Quarter financial results. View the full report at https://investor.kidoz.net/wp-content/uploads/2019/12/FRC-Q3-Research-Report.pdf.

For full details of the Company's operations and financial results, please refer to the Securities and Exchange Commission website at www.sec.gov or the Kidoz Inc. corporate website at https://investor.kidoz.net or on the www.sedar.com website.

About Kidoz Inc.

KIDOZ Inc. (TSXV:KIDZ) (www.kidoz.net) is the Internet of Kids (IoK). Engaging more than 100 million kids a month across our leading mobile KidTech network, KIDOZ provides an essential suite of services that unites kids' brands, content publishers and families. Trusted by Disney, Hasbro, Nintendo, Lego and more, the KIDOZ Safe Ad Network helps the world's largest brands to safely reach and engage kids across thousands of mobile apps and sites. The KIDOZ OS solution helps carriers and brands such as Lenovo, Acer, and PBS Kids bring a kid-focused experience to their family devices, in a fully GDPR and COPPA compliant way. KIDOZ's Rooplay (www.rooplay.com) offers an interactive learning experience worldwide with original content featuring Garfield, Moomin, Mr. Men, Little Miss, Mr. Bean and hundreds more kid-focused learning games.

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Certain information included in this press release (as well as information included in oral statements or other written statements made or to be made by the company) contains statements that are forward-looking, such as statements relating to anticipated future success of the company. Such forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future and, accordingly, such results may differ materially from those expressed in any forward-looking statements made by or on behalf of the company. For a description of additional risks and uncertainties, please refer to the company's filings with the Securities and Exchange Commission. Specifically, readers should read the Company's Annual Report on Form 10-K, filed with the SEC on March 21, 2019, and the prospectus filed under Rule 424(b) of the Securities Act on March 9, 2005 and the SB2 filed July 17, 2007, and the TSX Venture Exchange Listing Application for Common Shares filed on June 29, 2015 on SEDAR, for a more thorough discussion of the Company's financial position and results of operations, together with a detailed discussion of the risk factors involved in an investment in Kidoz Inc.

For further information, please contact:

Henry Bromley
CFO
ir@kidoz.net
(888) 374-2163

SOURCE: Kidoz Inc.

ReleaseID: 570230

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Armstrong Flooring, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 13, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Armstrong Flooring, Inc. ("Armstrong" or "the Company") (NYSE:AFI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between March 6, 2018 and November 4, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 14, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Armstrong artificially boosted its sales using a channel stuffing scheme. The Company failed to maintain effective controls on inventory. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Armstrong, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570231

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Correvio Pharma Corp. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 13, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Correvio Pharma Corp. ("Correvio" or "the Company") (NASDAQ:CORV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between October 23, 2018 and December 5, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before February 10, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Correvio's resubmission of a New Drug Application ("NDA") for Brinavess did not address significant health and safety issues observed in the Company's first NDA for the drug. The failure to minimize these problems significantly decreased the chances of the FDA approving Brinavess. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Correvio, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570217

STOCKHOLDER ALERT: Monteverde & Associates PC Reminds Investors of its Ongoing Investigation Regarding the Acquisition

NEW YORK, NY / ACCESSWIRE / December 13, 2019 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

Synthorx, Inc (THOR) relating to its sale to Sonafi. Under the terms of the Agreement, Synthorx shareholders will receive $68.00 in cash for each share of Synthorx common stock owned. Click here for more information: https://www.monteverdelaw.com/case/synthorx-inc. It is free and there is no cost or obligation to you.
Instructure, Inc (INST) related to its sale to PIV Purchaser, LLC. Under the terms of the Merger, each share of Instructure common stock will automatically be converted into the right to receive $47.60 in cash for each share of Instructure common stock owned. Click here for more information: https://www.monteverdelaw.com/case/instructure-inc. It is free and there is no cost or obligation to you.
Tech Data Corporation (TECD) related to its sale Tiger Midco, LLC. Under the terms of the Merger Agreement, Tech Data Shareholders have the right to receive $130.00 in cash for each Tech Data common stock owned. Click here for more information: https://www.monteverdelaw.com/case/tech-data-corporation. It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC

ReleaseID: 570227

URGENT NEWS: Monteverde & Associates PC Reminds Investors of its Ongoing Investigation Regarding the Merger

NEW YORK, NY / ACCESSWIRE / December 13, 2019 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating:

Audentes Therapeutics, Inc (BOLD) related to its sale to Astellas Pharma, Inc. Under the terms of the Agreement, Audentes shareholders will have the right to receive $60.00 in cash for each Audentes common stock owned. Click here for more information: https://www.monteverdelaw.com/case/audentes-therapeutics-inc. It is free and there is no cost or obligation to you.
Progenics Pharmaceuticals, Inc. (PGNX) related to its sale to Lantheus Holdings, Inc. Under the terms of the transaction, each share of Progenics common stock issued will automatically be converted into the right to receive 0.2502 of a share of Lantheus common stock for each share Progenics common stock. Click here for more information: https://www.monteverdelaw.com/case/progenics-pharmaceuticals-inc. It is free and there is no cost or obligation to you.
Central European Media Enterprises Ltd (CETV) related to its sale to TV Bidco B.V. Under the terms of the Agreement, Shareholders of CETV common stock will have the right to receive $4.58 in cash for each CETV common stock owned. Click here for more information: https://www.monteverdelaw.com/case/central-european-media-enterprises-ltd. It is free and there is no cost or obligation to you.

Monteverde & Associates PC is a national class action securities and consumer litigation law firm that has recovered millions of dollars and is committed to protecting shareholders and consumers from corporate wrongdoing. Monteverde & Associates lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct. Mr. Monteverde, who leads the legal team at the firm, has been recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019 an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer.

If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:

Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2019 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE: Monteverde & Associates PC

ReleaseID: 570226

BAX LOSSES ALERT: Bernstein Liebhard LLP Announces its Investigation of Baxter International, Inc.

NEW YORK, NY / ACCESSWIRE / December 13, 2019 / Bernstein Liebhard, a nationally acclaimed investor rights law firm, is investigating potential claims on behalf of shareholders of Baxter International, Inc. ("Baxter" or the "Company") (NYSE: BAX) resulting from allegations that Baxter might have issued misleading information to the investing public.

If you purchased Baxter securities, and/or would like to discuss your legal rights and options please visit Baxter Shareholder Investigation or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

On October 24, 2019, Baxter announced that it "recently began an investigation into certain intra-Company transactions undertaken for the purpose of generating foreign exchange gains or losses," and that according to the Company, "[t]hese transactions used a foreign exchange rate convention historically applied by the Company that was not in accordance with generally accepted accounting principles ("GAAP") and enabled intra-Company transactions to be undertaken after the related exchange rates were already known." The Company also admitted that these intra-Company transactions had "resulted in certain misstatements in the Company's previously reported non-operating income related to net foreign exchange gains" and acknowledged that upon completion of its investigation, "the Company expects to either amend its periodic reports previously filed with the SEC to include restated financial statements that correct those misstatements, or include in reports for future periods restated comparative financial statements that correct those misstatements."

Following this news, the price of Baxter common stock fell $8.87 per share, or 10.1%, from a close of $87.95 per share on October 23, 2019 to close at $79.08 per share on October 24, 2019, on elevated trading volume.

If you purchased Baxter securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/baxterinternationalinc-bax-shareholder-class-action-lawsuit-fraud-stock-230/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or MGuarnero@bernlieb.com.

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2019 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com

SOURCE: Bernstein Liebhard LLP

ReleaseID: 570223

Mota Ventures Corp. Enters Into Letter of Intent with Premier European Certified Organic and Ecological CBD Company Sativida

VANCOUVER, BC / ACCESSWIRE / December 13, 2019 / Mota Ventures Corp. (CSE:MOTA FSE: 1WZ:GR OTC: PEMTF) (the "Company" or "Mota") is pleased to announce that it has entered into a Letter of Intent (the "LOI") dated December 13, 2019, with VIDA BCN LABS SL (Spain) and Sativida OU (Estonia) (collectively, "Sativida") under which the Company will explore a potential acquisition of the business of Sativida. Sativida is a producer and online retailer of cannabidiol ("CBD") and branded CBD products in various jurisdictions in Europe, including Spain, Portugal, Austria, Germany, France and the United Kingdom.

Since inception in 2016, Sativida has grown revenues month over month on average 20%, and anticipates further significant growth through 2020. The Company expects to provide Sativida with contacts to distributors and partners across Europe and North America to allow for rapid expansion of the Sativida brand, as well as logistical and financial support.

Sativida currently develops and retails a vast range of organic CBD oils and cosmetics across Europe and is in the process of expanding its distribution network internationally to include the United States. It has become the number one search-ranked online retailer in Spain and Mexico and intends to continue its expansion into other countries in Europe and Latin America.

As a result of Sativida's high quality formulations, it has won multiple awards for product quality in Europe. Known for its minimal heavy metal content, and accurate CBD levels, Sativida is among the most well-respected CBD brands in the European market place. Its unique approach to customer education has allowed it to replicate its marketing strategy across multiple countries.

Joel Shacker, Chief Executive Officer of the Company, commented, "With the addition of Sativida to the Company's portfolio, we continue to increase shareholder value by bringing on companies that have existing revenue. The synergies that will be created between Ihuana SAS and Sativida will provide a runway for increased revenue, and sustainable growth. Additionally, this acquisition would allow the Company to develop as a vertically integrated business with international reach. We expect this acquisition to be the cornerstone for our entry into the European CBD market."

Noah Laith, CEO of Sativida remarked, "We are excited about the opportunity to work with Mota. An acquisition will give us access to experienced cannabis and finance industry teams, allowing us to scale up growth. With this acquisition, we will have access to the capital and resources required to achieve our goal of becoming a leader in CBD production and retail across international markets."

The final terms and structure for a transaction between the Company, and Sativida, have not yet been finalized. Completion of any transaction with Sativida remains subject to negotiation of definitive documentation, completion of customary due diligence and receipt of any required regulatory approvals. The Company will provide additional information regarding a transaction with Sativida as it becomes available.

About Mota Ventures Corp.

Mota is seeking to become a large-scale vertically integrated low-cost producer and exporter of the highest quality CBD products worldwide. The 2.5 hectare site located in Colombia has optimal year round growing conditions and access to all necessary infrastructure. The site is located approximately 2 hours outside of Bogota 20 minutes away from the free trade zone and 30 minutes away from the international airport. Phase one will consist of a state of the art 60,000 square foot greenhouse with the capacity to produce more than 14,000,000 grams per year along with build out of the Company's extraction facilities. The Company will focus on CBD extraction to produce pure raw CBD, with the goal to make value added CBD products and create its own brand to be sold internationally.

About Sativida

Sativida is a producer and online retailer of cannabidiol ("CBD") and branded CBD products in various jurisdictions in Europe, including Spain and the United Kingdom. Since inception in 2016, Sativida has grown revenues month over month on average 20%. Sativida currently develops and retails a vast range of organic CBD oils and cosmetics across Europe and is currently expanding its distribution network internationally. For more information on Sativida, readers are encouraged to review their website, www.sativida.com

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.
Joel Shacker
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, Chief Executive Officer at +1.236.521.2177 or by email at IR@motaventuresco.com or www.motaventuresco.com

This news release may contain certain "Forward-Looking Statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. When or if used in this news release, the words "anticipate", "believe", "estimate", "expect", "target, "plan", "forecast", "may", "schedule" and similar words or expressions identify forward-looking statements or information. These forward-looking statements or information may relate to the anticipated business activities of the Company and the reliability of third party information and other factors or information. Such statements represent the Company's current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social risks, contingencies and uncertainties. Many factors, both known and unknown, could cause results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements. Such factors include the results of a due diligence investigation of the business and operations of Sativida, and the final structure chosen for any transaction. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements and information other than as required by applicable laws, rules and regulations.

SOURCE: Mota Ventures Corp.

ReleaseID: 570207

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cintas Corporation and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 13, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cintas Corporation ("Cintas" or "the Company") (NASDAQ:CTAS) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Spruce Point Management published a research report about Cintas on November 13, 2019. According to the report, Cintas' Fire Protection Services directed workers to conduct fire and safety inspections without appropriate licenses and permits, and also falsified inspections. These practices reportedly led to fraud charges. Following the publication of this report, shares of Cintas traded down more than 4.25% in intraday trading.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570219

IMPORTANT DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Baozun Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / December 13, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Baozun Inc. ("Baozun" or "the Company") (NASDAQ:BZUN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between March 6, 2019 and November 20, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before February 10, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. One of Baozun's largest brand partners, Huawei, paid it add-on fees other partners did typically not pay, increasing the Company's revenues. This arrangement boosted the Company's revenues in the first half of 2019, only to abruptly drop them as Huawei restructured its online merchandising in the second half of the year. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Baozun, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570216

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of ADMS, BAX and AFI

NEW YORK, NY / ACCESSWIRE / December 13, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

Adamas Pharmaceuticals, Inc. (NASDAQGM:ADMS)

Investors Affected : August 8, 2017 – September 30, 2019

A class action has commenced on behalf of certain shareholders in Adamas Pharmaceuticals, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) health insurers were excluding Adamas's primary product, GOCOVRI, from their prescription formularies or requiring patients to use "step therapy" – i.e., making patients try immediate-release amantadine prior to covering GOCOVRI; (2) the rapid increase in physicians prescribing GOCOVRI during the Class Period was not due to its efficacy; and (3) as a result of the foregoing, the Company's financial statements about Adamas's business, operations, and prospects were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/adamas-pharmaceuticals-inc-loss-submission-form/?id=4883&from=1

Baxter International Inc. (NYSE:BAX)

Investors Affected : February 21, 2019 – October 23, 2019

A class action has commenced on behalf of certain shareholders in Baxter International Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) certain intra-Company transactions, undertaken for the purpose of generating foreign exchange gains and losses, used foreign exchange rate conventions that were not in accordance with GAAP and enabled intra-Company transactions to be undertaken after the related exchange rates were already known; (2) the Company lacked effective internal control over financial reporting; (3) as a result, the Company's financial statements were misstated and would likely require correction or amendment; (4) due to the Company's internal investigation, Baxter would not be able to file its quarterly report for the period ending September 30, 2019, with the SEC on Form 10-Q in a timely manner; and (5) as a result of the foregoing, Defendants' statements about the Company's business and operations lacked a reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/baxter-international-inc-loss-submission-form/?id=4883&from=1

Armstrong Flooring, Inc. (NYSE:AFI)

Investors Affected : March 6, 2018 – November 4, 2019

A class action has commenced on behalf of certain shareholders in Armstrong Flooring, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company's internal control over inventory levels was not effective; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis

Shareholders may find more information at https://securitiesclasslaw.com/securities/armstrong-flooring-inc-loss-submission-form/?id=4883&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 570210